Edwards Lifesciences Corporatio EW

$85.73 -2.11 (-2.40%)

Pullback · -1.53σ

+ Compare Open in Sniper

Mkt cap $51.9B

P/E 49.0

Day $85.30 – $87.06

52wk $74.66 – $96.29

Avg vol —

Beta —

Div yld —

Next earnings —

Quick read

Plain English

Edwards Lifesciences Corporatio is a healthcare company listed in the US.

EW last traded at $85.73, down 2.4% on the day; that's in the middle part of its 52-week range ($74.66–$96.29). Right now it's dipped below its recent average — a spot where watchers often look for signs the dip is stabilizing.

Earnings reports are the biggest scheduled catalysts to keep an eye on, and after the recent dip, watch whether the price stops making lower lows before assuming the worst is over.

A plain-English snapshot built from the data on this page — not investment advice. Always do your own research.

132-Day Trend Zones

Full chart →

21 EMA +1 ATR +2 ATR −2 ATR

—

O — H — L — C —

— —

Valuation & accounting

Valuation desk →

Our cash-flow model pegs fair value near $59.37 (fair range $31–$59); today's price sits 52% above that estimate. The model's verdict is “Overvalued” and accounting quality screens as Strong. Model estimates only — do your own due diligence.

Intrinsic (DCF)

$59.37

Fair-value range

$31.34 – $59.37

Margin of safety

-52%

Verdict

Overvalued

Accounting quality Strong

✓ More cash than debt
✓ Quick ratio 2.39 (antifragile)
✓ Current ratio 3.72 (antifragile)
✓ Debt/equity 0.32 (antifragile)

Price implies ~25% growth (vs trailing rev yoy). Model estimate — do your own due diligence.

Key statistics

All statistics →

EW is a $51.9 billion company, priced at 49× last year's earnings.

Mkt cap $51.9B

P/E ttm 49.0

Fwd P/E —

Beta —

Day range $85.30 – $87.06

52w range $74.66 – $96.29

Avg vol —

RSI(2) 9.3

ROE —

Net mgn —

FCF mgn 14.9%

Debt/Eq 0.07

Div yld —

Sector Healthcare

Industry Medical Devices

Next earn —

52-week range · today's price

$74.66$96.29